332 related articles for article (PubMed ID: 21229642)
21. Temozolomide and thalidomide in the treatment of glioblastoma multiforme.
Riva M; Imbesi F; Beghi E; Galli C; Citterio A; Trapani P; Sterzi R; Collice M
Anticancer Res; 2007; 27(2):1067-71. PubMed ID: 17465245
[TBL] [Abstract][Full Text] [Related]
22. Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma.
Ashizawa T; Miyata H; Iizuka A; Komiyama M; Oshita C; Kume A; Nogami M; Yagoto M; Ito I; Oishi T; Watanabe R; Mitsuya K; Matsuno K; Furuya T; Okawara T; Otsuka M; Ogo N; Asai A; Nakasu Y; Yamaguchi K; Akiyama Y
Int J Oncol; 2013 Jul; 43(1):219-27. PubMed ID: 23612755
[TBL] [Abstract][Full Text] [Related]
23. The mTOR inhibitor RAD001 potentiates autophagic cell death induced by temozolomide in a glioblastoma cell line.
Josset E; Burckel H; Noël G; Bischoff P
Anticancer Res; 2013 May; 33(5):1845-51. PubMed ID: 23645729
[TBL] [Abstract][Full Text] [Related]
24. [Retrospective analysis of 24 recurrent glioblastoma after chemoradiation and treated with nitrosoureas or irinotecan and bevacizumab].
Vauleon E; Mesbah H; Gedouin D; Lecouillard I; Louvel G; Hamlat A; Riffaud L; Carsin B; Quillien V; Audrain O; Lesimple T
Bull Cancer; 2012 Feb; 99(2):121-6. PubMed ID: 22257744
[TBL] [Abstract][Full Text] [Related]
25. BRM270, a Compound from Natural Plant Extracts, Inhibits Glioblastoma Stem Cell Properties and Glioblastoma Recurrence.
Jeon HY; Park CG; Ham SW; Choi SH; Lee SY; Kim JY; Seo S; Jin X; Kim JK; Eun K; Kim EJ; Kim H
J Med Food; 2017 Sep; 20(9):838-845. PubMed ID: 28792781
[TBL] [Abstract][Full Text] [Related]
26. Combination Therapy with AKT3 and PI3KCA siRNA Enhances the Antitumor Effect of Temozolomide and Carmustine in T98G Glioblastoma Multiforme Cells.
Paul-Samojedny M; Pudełko A; Kowalczyk M; Fila-Daniłow A; Suchanek-Raif R; Borkowska P; Kowalski J
BioDrugs; 2016 Apr; 30(2):129-44. PubMed ID: 26902608
[TBL] [Abstract][Full Text] [Related]
27. The prognostic value of nestin expression in newly diagnosed glioblastoma: report from the Radiation Therapy Oncology Group.
Chinnaiyan P; Wang M; Rojiani AM; Tofilon PJ; Chakravarti A; Ang KK; Zhang HZ; Hammond E; Curran W; Mehta MP
Radiat Oncol; 2008 Sep; 3():32. PubMed ID: 18817556
[TBL] [Abstract][Full Text] [Related]
28. Atracurium Besylate and other neuromuscular blocking agents promote astroglial differentiation and deplete glioblastoma stem cells.
Spina R; Voss DM; Asnaghi L; Sloan A; Bar EE
Oncotarget; 2016 Jan; 7(1):459-72. PubMed ID: 26575950
[TBL] [Abstract][Full Text] [Related]
29. Arsenic trioxide depletes cancer stem-like cells and inhibits repopulation of neurosphere derived from glioblastoma by downregulation of Notch pathway.
Wu J; Ji Z; Liu H; Liu Y; Han D; Shi C; Shi C; Wang C; Yang G; Chen X; Shen C; Li H; Bi Y; Zhang D; Zhao S
Toxicol Lett; 2013 Jun; 220(1):61-9. PubMed ID: 23542114
[TBL] [Abstract][Full Text] [Related]
30. Phase II pilot study of bevacizumab in combination with temozolomide and regional radiation therapy for up-front treatment of patients with newly diagnosed glioblastoma multiforme: interim analysis of safety and tolerability.
Lai A; Filka E; McGibbon B; Nghiemphu PL; Graham C; Yong WH; Mischel P; Liau LM; Bergsneider M; Pope W; Selch M; Cloughesy T
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1372-80. PubMed ID: 18355978
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI.
Yang YP; Chien Y; Chiou GY; Cherng JY; Wang ML; Lo WL; Chang YL; Huang PI; Chen YW; Shih YH; Chen MT; Chiou SH
Biomaterials; 2012 Feb; 33(5):1462-76. PubMed ID: 22098779
[TBL] [Abstract][Full Text] [Related]
32. Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma.
McDonald MW; Shu HK; Curran WJ; Crocker IR
Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):130-6. PubMed ID: 20399036
[TBL] [Abstract][Full Text] [Related]
33. Mitochondrial protein ATPase family, AAA domain containing 3A correlates with radioresistance in glioblastoma.
You WC; Chiou SH; Huang CY; Chiang SF; Yang CL; Sudhakar JN; Lin TY; Chiang IP; Shen CC; Cheng WY; Lin JC; Shieh SH; Chow KC
Neuro Oncol; 2013 Oct; 15(10):1342-52. PubMed ID: 24057885
[TBL] [Abstract][Full Text] [Related]
34. A novel 3D human glioblastoma cell culture system for modeling drug and radiation responses.
Gomez-Roman N; Stevenson K; Gilmour L; Hamilton G; Chalmers AJ
Neuro Oncol; 2017 Feb; 19(2):229-241. PubMed ID: 27576873
[TBL] [Abstract][Full Text] [Related]
35. Isolation and partial characterization of a new human glioblastoma cell line.
Brehar FM; Bleotu C; Stefan LM; Buzgariu W; Chivu M; Utoiu E; Matei L; Ciurea AV; Tascu A
Chirurgia (Bucur); 2009; 104(4):453-61. PubMed ID: 19886054
[TBL] [Abstract][Full Text] [Related]
36. STAT3 is essential for the maintenance of neurosphere-initiating tumor cells in patients with glioblastomas: a potential for targeted therapy?
Villalva C; Martin-Lannerée S; Cortes U; Dkhissi F; Wager M; Le Corf A; Tourani JM; Dusanter-Fourt I; Turhan AG; Karayan-Tapon L
Int J Cancer; 2011 Feb; 128(4):826-38. PubMed ID: 20473906
[TBL] [Abstract][Full Text] [Related]
37. Phase II study of bevacizumab and temsirolimus combination therapy for recurrent glioblastoma multiforme.
Lassen U; Sorensen M; Gaziel TB; Hasselbalch B; Poulsen HS
Anticancer Res; 2013 Apr; 33(4):1657-60. PubMed ID: 23564811
[TBL] [Abstract][Full Text] [Related]
38. Phase I study of arsenic trioxide and temozolomide in combination with radiation therapy in patients with malignant gliomas.
Grimm SA; Marymont M; Chandler JP; Muro K; Newman SB; Levy RM; Jovanovic B; McCarthy K; Raizer JJ
J Neurooncol; 2012 Nov; 110(2):237-43. PubMed ID: 22875709
[TBL] [Abstract][Full Text] [Related]
39. MSI1 associates glioblastoma radioresistance via homologous recombination repair, tumor invasion and cancer stem-like cell properties.
Lin JC; Tsai JT; Chao TY; Ma HI; Chien CS; Liu WH
Radiother Oncol; 2018 Nov; 129(2):352-363. PubMed ID: 30322656
[TBL] [Abstract][Full Text] [Related]
40. Treatment of primary glioblastoma multiforme with cetuximab, radiotherapy and temozolomide (GERT)--phase I/II trial: study protocol.
Combs SE; Heeger S; Haselmann R; Edler L; Debus J; Schulz-Ertner D
BMC Cancer; 2006 May; 6():133. PubMed ID: 16709245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]